This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trepod, C. M.
Right arrow Articles by Mott, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trepod, C. M.
Right arrow Articles by Mott, J. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2004, p. 1416-1418, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1416-1418.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Identification of the Haemophilus influenzae tolC Gene by Susceptibility Profiles of Insertionally Inactivated Efflux Pump Mutants

Catherine M. Trepod* and John E. Mott

Antibacterials, Pfizer, Groton, Connecticut 06340

Received 2 April 2003/ Returned for modification 3 June 2003/ Accepted 21 November 2003

Isogenic strains containing insertional disruptions of 10 Haemophilus influenzae Rd genes were investigated for their effects on the susceptibility of the organism to various classes of antimicrobial compounds. MIC results show that HI1462, which encodes an Escherichia coli TolC homolog, is the third component of the H. influenzae AcrAB pump.


* Corresponding author. Mailing address: Antibacterials, MS/8220-2343, Pfizer Inc., Groton, CT 06340. Phone: (860) 686-6810. Fax: (860) 715-4693. E-mail: catherine.m.trepod{at}pfizer.com.


Antimicrobial Agents and Chemotherapy, April 2004, p. 1416-1418, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1416-1418.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Caughlan, R. E., Sriram, S., Daigle, D. M., Woods, A. L., Buco, J., Peterson, R. L., Dzink-Fox, J., Walker, S., Dean, C. R. (2009). Fmt Bypass in Pseudomonas aeruginosa Causes Induction of MexXY Efflux Pump Expression. Antimicrob. Agents Chemother. 53: 5015-5021 [Abstract] [Full Text]  
  • Hatfaludi, T., Al-Hasani, K., Dunstone, M., Boyce, J., Adler, B. (2008). Characterization of TolC Efflux Pump Proteins from Pasteurella multocida. Antimicrob. Agents Chemother. 52: 4166-4171 [Abstract] [Full Text]  
  • Robertson, G. T., Doyle, T. B., Du, Q., Duncan, L., Mdluli, K. E., Lynch, A. S. (2007). A Novel Indole Compound That Inhibits Pseudomonas aeruginosa Growth by Targeting MreB Is a Substrate for MexAB-OprM. J. Bacteriol. 189: 6870-6881 [Abstract] [Full Text]  
  • Cerquetti, M., Giufre, M., Cardines, R., Mastrantonio, P. (2007). First Characterization of Heterogeneous Resistance to Imipenem in Invasive Nontypeable Haemophilus influenzae Isolates. Antimicrob. Agents Chemother. 51: 3155-3161 [Abstract] [Full Text]  
  • Dastidar, V., Mao, W., Lomovskaya, O., Zgurskaya, H. I. (2007). Drug-Induced Conformational Changes in Multidrug Efflux Transporter AcrB from Haemophilus influenzae. J. Bacteriol. 189: 5550-5558 [Abstract] [Full Text]  
  • Polleichtner, G., Andersen, C. (2006). The channel-tunnel HI1462 of Haemophilus influenzae reveals differences to Escherichia coli TolC. Microbiology 152: 1639-1647 [Abstract] [Full Text]  
  • Bogdanovich, T., Bozdogan, B., Appelbaum, P. C. (2006). Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae. Antimicrob. Agents Chemother. 50: 893-898 [Abstract] [Full Text]  
  • Dean, C. R., Narayan, S., Daigle, D. M., Dzink-Fox, J. L., Puyang, X., Bracken, K. R., Dean, K. E., Weidmann, B., Yuan, Z., Jain, R., Ryder, N. S. (2005). Role of the AcrAB-TolC Efflux Pump in Determining Susceptibility of Haemophilus influenzae to the Novel Peptide Deformylase Inhibitor LBM415. Antimicrob. Agents Chemother. 49: 3129-3135 [Abstract] [Full Text]  
  • van Amsterdam, K., Bart, A., van der Ende, A. (2005). A Helicobacter pylori TolC Efflux Pump Confers Resistance to Metronidazole. Antimicrob. Agents Chemother. 49: 1477-1482 [Abstract] [Full Text]  
  • Trepod, C. M., Mott, J. E. (2005). Elucidation of Essential and Nonessential Genes in the Haemophilus influenzae Rd Cell Wall Biosynthetic Pathway by Targeted Gene Disruption. Antimicrob. Agents Chemother. 49: 824-826 [Abstract] [Full Text]